Patrick J. Roberts

CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation

Jiehui Deng, Eric S. Wang, Russell W. Jenkins et al. · Cancer Discovery · 2017 · 781 citations · Full text

Life Sciences, Immunology, Oncology +17

A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response

Chen Zhao, Katherine A. Cheng, Zandra E. Walton et al. · Nature · 2012 · 451 citations

Medicine, Genetics, Oncology +10

Rho Family GTPase Modification and Dependence on CAAX Motif-signaled Posttranslational Modification

Patrick J. Roberts, Natalia Mitin, Patricia J. Keller et al. · Journal of Biological Chemistry · 2008 · 361 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13

Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types

Matthew D. Wilkerson, Xiaoying Yin, Katherine A. Hoadley et al. · Clinical Cancer Research · 2010 · 295 citations · Full text

Medicine, Bioinformatics, Oncology +17

Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer Therapy

Patrick J. Roberts, John Bisi, Jay C. Strum et al. · JNCI Journal of the National Cancer Institute · 2012 · 252 citations · Full text

Medicine, Cancer Biology, Oncology +17